Combined HP 13C Pyruvate and 13C-Glucose Fluxomic as a Potential Marker of Response to Targeted Therapies in YUMM1.7 Melanoma XenograftsChantale Farah, Bénédicte F. Jordan|Biomedicines|2022Cited by 7